Daniel Lysák

9PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 12, 2026
Comparable outcomes of BTK inhibitors and fixed-duration venetoclax plus rituximab in second-line treatment of chronic lymphocytic leukaemia: a real-world analysis by the Czech CLL study group.

|Dec 17, 2025
Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition.

Ganesh Ramesh, Zsolt Sebestyen, Anil Kumar Deshantri

|Feb 07, 2023
A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients.

Tomas Reischig, Tomas Vlas, Martin Kacer

|Dec 23, 2022
Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies.

Diana Cenariu, Horia Bumbea, Anca Colita

|Jun 02, 2021
Should We Stop Collecting the Preoperative Autologous Blood before Bone Marrow Harvest?

Daniel Lysák, Lenka Hejretová, Marcela Hrabětová

|Apr 30, 2021
Mesenchymal Stromal Cell Therapy in Novel Porcine Model of Diffuse Liver Damage Induced by Repeated Biliary Obstruction.

Lucie Vištejnová, Václav Liška, Arvind Kumar

Pageof 2

Frequent Collaborators

3 joint publications

Monika Holubova

1 joint publications

M Čedíková

1 joint publications

P Jindra

1 joint publications

Pavel Pitule